Eagle Pharmaceuticals Inc
(EGRX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
by (Cboe BZX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
[[ item.lastPriceExt ]]
[[ item.priceChangeExt ]]
([[ item.percentChangeExt ]])
[[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 06-2013 | 03-2013 | 09-2012 | |
| Cash Flows From Operating Activities | |||
| Net Income | -6,532 | -7,286 | -19,380 |
| Depreciation Amortization | 1,293 | 791 | 470 |
| Accounts receivable | 1,264 | 89 | N/A |
| Accounts payable and accrued liabilities | 195 | 2,557 | N/A |
| Other Working Capital | -979 | 3,170 | 2,810 |
| Other Operating Activity | -804 | -2,152 | 560 |
| Operating Cash Flow | $-5,564 | $-2,831 | $-15,540 |
| Cash Flows From Investing Activities | |||
| Change In Deposits | 1,500 | 1,500 | N/A |
| PPE Investments | -31 | N/A | -30 |
| Other Investing Activity | 0 | 0 | 2,990 |
| Investing Cash Flow | $1,469 | $1,500 | $2,960 |
| Cash Flows From Financing Activities | |||
| Other Financing Activity | 9,829 | -83 | 9,540 |
| Financing Cash Flow | $9,829 | $-83 | $9,540 |
| Beginning Cash Position | 5,067 | 5,067 | 8,100 |
| End Cash Position | 10,801 | 3,653 | 5,060 |
| Net Cash Flow | $5,735 | $-1,414 | $-3,030 |
| Free Cash Flow | |||
| Operating Cash Flow | -5,564 | -2,831 | -15,540 |
| Capital Expenditure | -31 | N/A | N/A |
| Free Cash Flow | -5,594 | -2,831 | -15,540 |